Results 101 to 110 of about 29,167 (216)

Salbutamol inhibits trypsin-mediated production of CXCL8 by keratinocytes.

open access: yes, 2006
Treatment of primary keratinocytes (HEKAp) with trypsin led to the production and release of CXCL8. Production of CXCL8 was exquisitely sensitive to inhibition by co-treatment with the beta(2) agonist sabutamol (IC(50)=1.1 nM).
Roy Pettipher   +2 more
core   +1 more source

Comparative study of the bronchodilator efficacy and adverse effects of salbutamol and hyoscine butylbromide in horses with severe asthma

open access: yesJournal of Veterinary Internal Medicine
Background Salbutamol and hyoscine butylbromide (HBB) are commonly used bronchodilators in horses with severe asthma (SA). Objective To compare the bronchodilation potency, duration, and adverse effects of salbutamol and HBB in SA.
Berta Mozo Vives   +2 more
doaj   +1 more source

The Modulatory Effects of Salbutamol in the Basolateral Nucleus of the Amygdala on Learning and Memory Impairments Induced by Foot-shock Stress in the Male Rat

open access: yesمجله علمی دانشگاه علوم پزشکی کردستان, 2021
Background and Aim: Beta-adrenergic receptors in the basolateral nucleus of the amygdala (BLA) have been associated with stress, learning, and memory. In this study, we tested the effects of intra-BLA microinfusions of the β2-adrenergic receptor agonist,
Gholam Hossein Meftahi   +3 more
doaj  

Comparing the Efficacy of 7o/o , 3o/o and 09o/o Saline in Moderate to Severe Bronchiolitis in Infants

open access: yesBalkan Medical Journal, 2016
Background: There is no standard treatment option in acute bronchiolitis. 3-7% hypertonic saline (HS) seems to be the effective treatment choice for reducing the hospitalization day.
Seçil Köse   +11 more
doaj   +1 more source

Beta2-adrenergic agonist salbutamol exhibits enantioselective disposition in skeletal muscle of lean young men following oral administration

open access: yes
Salbutamol is a common short-acting beta2-adrenergic agonist used in treatment of asthma and exercise-induced bronchoconstriction but also possesses anabolic and metabolic actions in skeletal muscle.
Hostrup, Morten   +5 more
core   +1 more source

Emergency room management of acute bronchiolitis: a randomized trial of nebulized epinephrine

open access: yesThe Turkish Journal of Pediatrics, 2011
Acute bronchiolitis is a common, potentially life-threatening condition with few therapeutic options. In the present randomized study, we compared the clinical efficacies of nebulized epinephrine and salbutamol in the emergency room management of ...
Pelin Ozlem Simşek-Kiper   +6 more
doaj  

(R)-salbutamol in the treatment of asthma and chronic obstructive airways disease

open access: yes, 2011
Areas covered: In this review the authors show that (R)-salbutamol alone (generically known as levosalbutamol) provides beneficial beta beta(2)-agonist effects at a cellular level and in experimental models of airways disease.
Neil C Thomson   +3 more
core   +1 more source

Inhaled Beta-2 Agonist Salbutamol for the Treatment of Transient Tachypnea of the Newborn

open access: yes, 2011
Objective To evaluate the efficacy of inhaled salbutamol, a beta-2 adrenergic agonist, for the treatment of transient tachypnea of the newborn (TTN) and to determine whether inhaled salbutamol is safe in newborn ...
Tekinalp, Gulsevin   +9 more
core   +1 more source

Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle.

open access: yes, 2013
Montelukast (MK) is a potent cysteinyl-leukotriene receptor antagonist that causes dose-related improvements in chronic asthma. We sought to determine whether MK was able to prevent salbutamol-induced tolerance in airway smooth muscle.
FOGLI, STEFANO   +8 more
core   +1 more source

Salbutamol Residues in Swine Tissues and Body Fluids after Feeding

open access: yes, 2014
Salbutamol residues in swine tissues and fluids were investigated. Tissue, serum and urine samples were collected from 33 pigs after 14 days of oral administration of 3 ppm salbutamol.
Wu, Y.J.   +5 more
core  

Home - About - Disclaimer - Privacy